Compression of the trigeminal ganglion produces prolonged nociceptive behavior in rats.
The present study is the first demonstration of prolonged nociceptive behavior in the trigeminal region following compression of the trigeminal ganglion in rats. Experiments were carried out on male Sprague-Dawley rats mounted onto a stereotaxic frame under pentobarbital sodium anesthesia. For compression of the trigeminal ganglion, a 4% agar solution (8microl) was injected into the trigeminal ganglion through a stainless steel injector (24 gauge), which extended 2mm beyond the end of a guide cannula (21 gauge). Following agar injection, the injector and guide cannula were removed. In the control group, rats were sham operated without agar injection. Air-puff thresholds (mechanical allodynia), pin prick responses (mechanical hyperalgesia), and spontaneous scratching behavior were examined 3 days before surgery and at 3, 7, 10, 14, 17, 21, 24, 30, and 40 days after surgery. Data were analyzed using a repeated measures ANOVA followed by multiple group comparisons using the LSD post-hoc test. Air-puff thresholds significantly decreased after compression of the trigeminal ganglion. Mechanical allodynia was established within 3 days and lasted beyond postoperative day 24. Mechanical hyperalgesia was also evident 3 days after compression and persisted until the 40th postoperative day. Although mechanical allodynia and hyperalgesia appeared bilaterally, the ipsilateral side was significantly more sensitive. Intraperitoneal treatment with carbamazepine significantly blocked mechanical allodynia produced by compression of the trigeminal ganglion. These findings suggest that prolonged nociceptive behavior following compression of the trigeminal ganglion may mimic trigeminal neuralgia in this animal model.
Ahn
Dong K
DK
Department of Oral Physiology, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea. dkahn@knu.ac.kr
Lim
Eun J
EJ
Kim
Byung C
BC
Yang
Gwi Y
GY
Lee
Min K
MK
Ju
Jin S
JS
Han
Seung R
SR
Bae
Yong C
YC
D000362:Agar; D018712:Analgesics, Non-Narcotic / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D002220:Carbamazepine / Q000494:pharmacology; D005157:Facial Pain / Q000523:psychology; D007839:Functional Laterality / Q000187:drug effects; D006120:Grooming / Q000187:drug effects; D006930:Hyperalgesia / Q000188:drug therapy / Q000523:psychology; D008297:Male; D010146:Pain / Q000209:etiology / Q000473:pathology / Q000523:psychology*; D010147:Pain Measurement / Q000187:drug effects; D010812:Physical Stimulation; D004856:Postural Balance / Q000187:drug effects; D011312:Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley; D012668:Trigeminal Ganglion / Q000473:pathology / Q000502:physiology*; D014277:Trigeminal Neuralgia / Q000473:pathology / Q000523:psychology*
D018712:Analgesics, Non-Narcotic; D002220:Carbamazepine; D000362:Agar